These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17095500)

  • 1. Use of methylene blue in sepsis: a systematic review.
    Kwok ES; Howes D
    J Intensive Care Med; 2006; 21(6):359-63. PubMed ID: 17095500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.
    Weingartner R; Oliveira E; Oliveira ES; Sant'Anna UL; Oliveira RP; Azambuja LA; Friedman G
    Braz J Med Biol Res; 1999 Dec; 32(12):1505-13. PubMed ID: 10585632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylene blue for the treatment of septic shock.
    Paciullo CA; McMahon Horner D; Hatton KW; Flynn JD
    Pharmacotherapy; 2010 Jul; 30(7):702-15. PubMed ID: 20575634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
    Park BK; Shim TS; Lim CM; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
    Korean J Intern Med; 2005 Jun; 20(2):123-8. PubMed ID: 16134766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.
    Juffermans NP; Vervloet MG; Daemen-Gubbels CR; Binnekade JM; de Jong M; Groeneveld AB
    Nitric Oxide; 2010 May; 22(4):275-80. PubMed ID: 20109575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylene blue administration in septic shock: a clinical trial.
    Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
    Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene blue increases myocardial function in septic shock.
    Daemen-Gubbels CR; Groeneveld PH; Groeneveld AB; van Kamp GJ; Bronsveld W; Thijs LG
    Crit Care Med; 1995 Aug; 23(8):1363-70. PubMed ID: 7634806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?
    Donati A; Conti G; Loggi S; Münch C; Coltrinari R; Pelaia P; Pietropaoli P; Preiser JC
    Crit Care Med; 2002 Oct; 30(10):2271-7. PubMed ID: 12394955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of methylene blue in refractory septic shock: study protocol for a multicenter, randomized, placebo-controlled trial.
    Jia J; Ji J; Liu Z
    Trials; 2024 Sep; 25(1):630. PubMed ID: 39334256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.
    Gachot B; Bedos JP; Veber B; Wolff M; Regnier B
    Intensive Care Med; 1995 Dec; 21(12):1027-31. PubMed ID: 8750129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration.
    Mount JC; Rowe AS
    Pharmacotherapy; 2010 Mar; 30(3):323. PubMed ID: 20180614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged methylene blue infusion in refractory septic shock: a case report.
    Dumbarton TC; Minor S; Yeung CK; Green R
    Can J Anaesth; 2011 Apr; 58(4):401-5. PubMed ID: 21246318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylene Blue Reduces Mortality in Critically Ill and Perioperative Patients: A Meta-Analysis of Randomized Trials.
    Pruna A; Bonaccorso A; Belletti A; Turi S; Di Prima AL; D'amico F; Zangrillo A; Kotani Y; Landoni G
    J Cardiothorac Vasc Anesth; 2024 Jan; 38(1):268-274. PubMed ID: 37880041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange.
    Andresen M; Dougnac A; Díaz O; Hernández G; Castillo L; Bugedo G; Alvarez M; Dagnino J
    J Crit Care; 1998 Dec; 13(4):164-8. PubMed ID: 9869542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene blue reverses endotoxin-induced hypotension.
    Keaney JF; Puyana JC; Francis S; Loscalzo JF; Stamler JS; Loscalzo J
    Circ Res; 1994 Jun; 74(6):1121-5. PubMed ID: 8187278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
    Saha BK; Burns SL
    Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study.
    Kirov MY; Evgenov OV; Evgenov NV; Egorina EM; Sovershaev MA; Sveinbjørnsson B; Nedashkovsky EV; Bjertnaes LJ
    Crit Care Med; 2001 Oct; 29(10):1860-7. PubMed ID: 11588440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations.
    Schneider F; Lutun P; Hasselmann M; Stoclet JC; Tempé JD
    Intensive Care Med; 1992; 18(5):309-11. PubMed ID: 1527264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.
    Tchen S; Sullivan JB
    J Crit Care; 2020 Jun; 57():148-156. PubMed ID: 32145658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.